Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Molecular Diagnostics Market By Type (Instruments, Software and Services, Reagents & Kits) By Technology (Hybridization, Polymerase Chain Reaction (PCR), Microarray, DNA Sequencing ) By Users(Hospitals, Laboratories) - Global Opportunity, Analysis and Industry Forecast, 2018-2023.

 Healthcare and Pharmaceuticals

Report Overview

Global Molecular Diagnostics Market was valued at USD 6.72 Billion in the year 2017. Global Molecular Diagnostics market is further expected to grow at a CAGR of 11. 60% from 2018 to reach USD 12.98 Billion by the year 2023. North America region holds the highest market share in 2017. While Asia Pacific region is considered as the fastest growing market in the forecasted period. The U.S. is the major market in 2017 at country level and it is further anticipated to grow at a steady pace in the next 5 years.

Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key manufacturers in the Global Molecular Diagnostics market with highest market share was held by Roche Diagnostics for better global presence both at production and at an operational level. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key market drivers. Organic growth strategies adopted by most of Tier 1 and Tier 2 manufacturers in recent years is also providing comprehensive market opportunities for the various stakeholder.

Drivers

            Molecular diagnostics advancements

            Growing infectious disease market

Restrain

            Lack of regulatory standards

            Level of required financial investment & lack of technical expertise

Opportunity

            Rising importance of diagnostics in improving healthcare quality

            Development of emerging markets for Point of care testing.

Challenge

            Intense competition and reduced healthcare reimbursement

By type, the market is segmented as instruments, software and Services and Reagents & Kits. The Polymerase Chain Reaction (PCR) is likely to hold the top market share during the forecast period among all other technology segments. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income). On the other hand, hospitals & clinical Laboratories for users is expected to grow at the highest CAGR of XXX during the year 2018-2023.

By type                        

Introduction                  

Instruments                  

Software and Services               

Reagents & Kits                                                 

By Technology                        

Hybridization                 

Polymerase Chain Reaction (PCR)                       

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

DNA Sequencing           

Others  

By Users                                 

Hospitals                      

Laboratories

Others  

By Region

North America

Europe

Asia-Pacific

RoW

Key Players

1. Abbott Laboratories (U.S.)                   

2. Beckman Coulter Inc. (U.S.)               

3. Biomérieux SA (France)         

4. Grifols SA (Spain)      

5. F. Hoffmann-La Roche AG (U.S.)                     

6. Becton, Dickinson and Company (U.S.)            

7. Qiagen Netherlands (includes Digene) (Netherlands)                 

8. Danaher Corporation (Beckman Coulter) Lab 21 (US)               

9. Agilent Technologies (Dako) (U.S)

10. Trinity Biotech (Ireland)

(A brief overview of another 13 companies is also provided) 

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Molecular Diagnostics Market by type                                

6.1 Introduction            

6.2 Instruments            

6.3 Software and Services                     

6.4 Reagents & Kits    

7. Molecular Diagnostics Market by Technology                                 

7.1 Hybridization                       

7.2 Polymerase Chain Reaction (PCR)                 

7.3 Microarray

7.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

7.5 DNA Sequencing      

7.6 Others                       

8. Molecular Diagnostics Market by Users                              

8.1 Hospitals                 

8.2 Laboratories

8.3 Others                  

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. Germany

       9.3.2. France

       9.3.3. U.K.

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. China

       9.4.2. Japan

       9.4.3. India

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America

             9.5.1.1. Brazil

             9.5.1.2. Argentina

             9.5.1.3. Rest of Latin America

       9.5.2. Middle East and Africa

10. Company Profile                                 

(Business Overview, Patents & Standards, Financial Overview*, Product Portfolio, Recent Developments)                             

10.1 Abbott Laboratories (U.S.)               

10.2 Beckman Coulter Inc. (U.S.)           

10.3 Biomérieux SA (France)      

10.4 Grifols SA (Spain)  

10.5 F. Hoffmann-La Roche AG (U.S.)                  

10.6 Becton, Dickinson and Company (U.S.)        

10.7 Qiagen Netherlands (includes Digene) (Netherlands) 

10.8 Danaher Corporation (Beckman Coulter) Lab 21 (U.S.)          

10.9 Agilent Technologies (Dako) (U.S.)  

10.10 Trinity Biotech (Ireland)     

(A brief overview of another 13 companies is also provided)            

*Details Might Not Be Captured in Case of Unlisted Companies

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

Summary

No Content Available.